GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $12,000 | -73.9% | 34,197 | +3.4% | 0.00% | – |
Q1 2015 | $46,000 | -24.6% | 33,074 | +11.9% | 0.00% | – |
Q3 2014 | $61,000 | -37.1% | 29,559 | -6.4% | 0.00% | -100.0% |
Q2 2014 | $97,000 | +32.9% | 31,566 | -2.1% | 0.00% | – |
Q3 2013 | $73,000 | +180.8% | 32,243 | +180.2% | 0.00% | – |
Q2 2013 | $26,000 | – | 11,507 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hoxton Financial, Inc. | 50,000 | $74,000 | 0.04% |
Alyeska Investment Group, L.P. | 1,593,277 | $2,342,000 | 0.02% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 31,000 | $46,000 | 0.02% |
GROUP ONE TRADING, L.P. | 1,346,904 | $1,980,000 | 0.02% |
Matisse Capital | 17,000 | $25,000 | 0.01% |
COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $22,000 | 0.01% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 12,150 | $18,000 | 0.01% |
EQUITEC SPECIALISTS, LLC | 19,700 | $29,000 | 0.01% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 153,375 | $225,000 | 0.00% |
OPPENHEIMER & CO INC | 94,300 | $138,000 | 0.00% |